Léa Payen
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 58
- Drug Transport and Resistance Mechanisms 39
- Cancer Cells and Metastasis 8
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Olivier Fardel (22 shared papers)Arnaud Courtois (15 shared papers)André Guillouzo (15 shared papers)Laurent Vernhet (5 shared papers)Jérôme Guitton (18 shared papers)David Bernard (7 shared papers)Susan P.C. Cole (3 shared papers)Mian Gao (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Oncotarget (4 papers)Cancers (4 papers)Biochemical Pharmacology (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Léa Payen
92 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Oncology 963
- Pharmacology 207
- Pediatrics, Perinatology and Child Health 291
- Cancer Research 222
- Molecular Biology 718
Countries citing papers authored by Léa Payen
This map shows the geographic impact of Léa Payen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Payen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Payen more than expected).
Fields of papers citing papers by Léa Payen
This network shows the impact of papers produced by Léa Payen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Payen. The network helps show where Léa Payen may publish in the future.
Co-authors
The 25 scholars most cited alongside Léa Payen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 138 | |
| 2 | 2013 | 130 | |
| 3 | 1999 | 87 | |
| 4 | 2001 | 83 | |
| 5 | 2005 | 72 | |
| 6 | 2003 | 67 | |
| 7 | 1999 | 66 | |
| 8 | 2002 | 65 | |
| 9 | 2000 | 63 | |
| 10 | 2016 | 55 | |
| 11 | 2010 | 54 | |
| 12 | 2001 | 53 | |
| 13 | 2000 | 51 | |
| 14 | 2001 | 50 | |
| 15 | 2010 | 41 | |
| 16 | 2008 | 38 | |
| 17 | 2014 | 37 | |
| 18 | 2021 | 32 | |
| 19 | 2011 | 31 | |
| 20 | 2008 | 31 |
About Léa Payen
Léa Payen is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 97 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (39 papers), Pharmacological Effects and Toxicity Studies (12 papers), Cancer therapeutics and mechanisms (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (8 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (963 citations), Pharmacology (207 citations), Pediatrics, Perinatology and Child Health (291 citations), Cancer Research (222 citations) and Molecular Biology (718 citations). Léa Payen has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Olivier Fardel, Arnaud Courtois, André Guillouzo, Laurent Vernhet, Jérôme Guitton, David Bernard, Susan P.C. Cole, Mian Gao, Christopher J. Westlake and Jessica Garcia. Their work appears in journals such as Biochemical and Biophysical Research Communications, Oncotarget, Cancers, Biochemical Pharmacology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.